Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated April 27, 2023, in Post-Effective Amendment No. 1 to the Registration Statement (Form F-1 No. 333-266050) and related Prospectus of Evaxion Biotech A/S for the registration of 4,649,250 ordinary shares.
/s/ EY Godkendt Revisionspartnerselskab
Copenhagen, Denmark
August 25, 2023